A meta-analysis of the prevalence of Toxoplasma gondii in animals and humans in Ethiopia by Endrias Zewdu Gebremedhin & Getachew Tadesse
Gebremedhin and Tadesse Parasites & Vectors  (2015) 8:291 
DOI 10.1186/s13071-015-0901-7RESEARCH Open AccessA meta-analysis of the prevalence of Toxoplasma
gondii in animals and humans in Ethiopia
Endrias Zewdu Gebremedhin1 and Getachew Tadesse2*Abstract
Background: Toxoplasmosis is a worldwide zoonosis. The objectives of this study were to estimate the prevalence
and assess the potential risk factors of Toxoplasma gondii infections in animals and humans in Ethiopia by using
meta-analytical methods.
Methods: Published studies on T. gondii in animals and humans in Ethiopia were searched in Medline, Google Scholar
and the lists of references of articles. Eligible studies were selected by using inclusion and exclusion criteria. The risks of
within and across study biases, and the variations in prevalence estimates attributable to heterogeneities were assessed.
Pooled prevalence was estimated by the DerSimonian and Laird random effects model.
Results: Thirty two studies were eligible and data from 5689 animals and 5718 humans were used for quantitative
syntheses. The pooled IgG seroprevalence in cats, small ruminants and humans were estimated at 87.72 %
(95 % CI = 78.63, 93.28), 34.59 % (95 % CI = 21.08, 51.12) and 74.73 % (95 % CI = 61.85, 84.36), respectively. The odds of
infections were higher in pregnant than in non pregnant women (OR = 3.96), in individuals that had contact with cats
than those with no contact (OR = 2.53), and in urban than in rural inhabitants (OR = 2.06).
Conclusions: Toxoplasmosis is highly prevalent and could be a cause of considerable reproductive wastage in small
ruminants and multiple diseases in humans in Ethiopia. Public education on preventive measures could help reduce
the transmission of the parasite to humans.
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Toxoplasma gondii is a widespread zoonotic parasite
that infects all warm-blooded animals and humans [1].
Felids are its definitive hosts and excrete oocysts in their
feces [2, 3], and the oocyst burden in areas where cats
selectively defecate is high [4]. Animals and humans
acquire infections mainly by ingesting food or water
contaminated with sporulated oocysts and tissue cysts [5].
Although most infections are asymptomatic, reproductive
losses in animals [6] and multiple disorders, that include
cognitive impairment and fatal encephalitis in humans
could come about [7, 8]. Additionally, there are reports
of associations between T. gondii infections with schizo-
phrenia [9, 10], bipolar disorder [11, 12], suicide [13],
epilepsy [14] and traffic accidents [15, 16].* Correspondence: getadesse1@yahoo.com
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article, unless otherwise stated.Despite T.gondii being an important zoonotic pathogen,
there is no national survey that addressed the multiple
disorders it causes in humans, its impact in animal
production, its temporal and spatial distribution and
the risk factors associated with the occurrence of the
disease in Ethiopia. The objectives of this study were
to estimate the prevalence of T. gondii infection in
cats, food animals and humans in Ethiopia, and assess
the potential risk factors of infection.Methods
The study was conducted according to the PRISMA
guideline (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses) [17]. The PRISMA checklist
was used to ensure inclusion of relevant information in
the analysis (see Additional file 1).ioMed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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Published studies were searched in Medline. Non-Medline
indexed articles were searched in Google Scholar and the
lists of references of articles. Toxoplasm* and Ethiopia
were the main MeSH terms used in electronic searches.
Additional searches were done by using the main MeSH
terms, Boolean operators, prevalence, incidence, cats,
cattle, sheep, goats, camels, pigs, chicken and humans.
The last search was done on December 23, 2014. Full text
articles were downloaded or obtained from the library of
the school of Medicine, College of Health Sciences, Addis
Ababa University, and from Dr. Jitender P. Dubey.
Selection of studies
A study was eligible for quantitative analyses if (i) it was
published in English, (ii) it was cross-sectional, (iii) the
methods were coprological and/or serological [Sabin
Feldman dye test (SFT), modified agglutination test
(MAT), modified direct agglutination test (MDAT),
direct agglutination test (DAT), enzyme linked immuno-
sorbent assay (ELISA) and latex agglutination test (LAT)],
and (iv) the sample size was greater than 35. Studies were
excluded if the titles and abstracts were not relevant to
the outcomes of interest or did not fulfill the eligibility
criteria.
Data extraction
From each eligible study, the following data were extracted:
the first author, year of publication, year of study, location,
climatic zone, altitude, study design, sample size, species,
sex, age group, test methods and the number of positive
samples. In addition, from studies on humans, the following
were extracted: setting (hospital/non-hospital), pregnancy
status (pregnant/non pregnant), HIV status (HIV positive/
HIV negative), residence (urban/rural), behavior (apparently
normal/abnormal), raw meat (consumer/non consumer),
raw vegetable (consumer/non consumer), presence of
cats in the household/contact (yes/no) and water source
(pipe/others).
Data analysis
Data on cats, food animals and humans were analyzed
separately. The study level estimates were transformed to
logit event estimates [18, 19] by the following formula:
lp = ln [p/ (1 − p)], where lp = logit event estimate;
ln = natural logarithm; p = study level estimate. The vari-
ances of the estimates were calculated by the following
formula: v (lp) = 1/(np) + 1/ [n (1 − p)], where v = variance
and n = sample size.
Bias and heterogeneity analyses
The qualities of the study methods (study design and
serological tests) were used to assess the within study
biases. The across study bias (small study effects) wasexamined by funnel plots, and the statistical significance
was assessed by the Egger’s regression asymmetry test
[20]. The Duval and Tweedie non-parametric ‘fill and trim’
linear random method was used to calculate unbiased esti-
mates [21]. The heterogeneities of study level estimates
were assessed by Galbraith plot [22] and Cochran’s Q test.
A non significant heterogeneity was accepted if the ratio of
Q and the degree of freedom (Q/df) was less than one.
The percentage of the variation in prevalence esti-
mates attributable to heterogeneity was quantified by
the inverse variance index (I2), and I2 values of 25 %,
50 % and 75 % were considered as low, moderate and
high heterogeneity, respectively [23]. Subgroup ana-
lyses were done if the heterogeneities were moderate
to high. A study was included in a subgroup analysis
if the number of individuals (n) was more than 25 %
of the mean of the subgroup.Pooling and sensitivity tests
The DerSimonian and Laird random effects model was
used to pool logit event estimates [24]. Pooled logit
estimates were transformed to prevalence estimates
(p) by the following formula: p = elp/ (elp + 1): where
e = the base of natural logarithm. Single study omitted
influence analyses were done to test the robustness of
a pooled estimate, and a study was considered to
have no influence if the pooled estimate without it
was within the 95 % confidence limits of the overall
mean. The Z test was used to test whether a pooled
estimate significantly differs from zero or not. The
Yates corrected Chi Square test was used to test the
significance of a difference between estimates [25, 26].
Alpha was set at 0.05.
Microsoft Office Excel 2007 was used to transform
study level estimates to logit event estimates, and to back
transform pooled logit event estimates to prevalence
estimates. Epi infoTM (Version 3.5.1, Center for Disease
Control, CDC, USA) was used to compare groups. Stata
(Version 11.1, Stata Corp, College Station, Texas) was
used in all other analyses.Results
Search results and eligible studies
Figure 1 shows the search results. A total of 63 studies
were found of which 18 were excluded based on the
titles and abstracts. Of the studies screened for eligibility,
12 were excluded due to the following reasons: one was
not available; two were abstracts; the sample size was 20
in one; the data was inconsistent in one; the diagnosis
was established on the basis of clinical signs in one;
IHAT was used in three, and the methods were not
described in three studies. A total of 32 full-text studies
were used for quantitative analyses [27–58].
Fig. 1 Flow diagram of the selection of eligible studies
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On the whole, data from 5689 animals (124 cats, 1950
sheep, 2102 goats, 726 chickens, 402 pigs and 385 camels)
and 5718 humans from several regions of Ethiopia were
analyzed (Table 1).
Bias and heterogeneity assessment
All studies on animals were cross-sectional, and the
serological tests were ELISA, DAT, MDAT and MAT.
All studies on humans were cross-sectional and IgG
seroprevalence was examined by using ELISA, LAT,
SFDT and MDAT. According to the manufacturers of
the kits, the sensitivities and specificities of the tests
were > = 92 %, and > = 95 %, respectively. As the sensi-
tivity and specificity of LAT was lower than those of the
other tests, a subgroup analysis of the estimates of
human studies that used LAT vs. other tests did not
yield a statistically significant difference (p > 0.05). The
funnel plots (Fig. 2) and the bias coefficients in both
food animal [b = 0.54 (95 % CI = −19.27, 20.35; p > 0.05),
and human [b = 5.45 (95 % CI = −4.67, 15.57; p > 0.05)
studies did not suggest the presence of bias, and no
theoretical missing study was incorporated by the Duval
and Tweedie non-parametric method. The percentagesof the variations in prevalence estimates attributable to
heterogeneities were zero, 97.6 % and 98.6 % in cat, food
animal and human studies, respectively.
Pooled prevalence estimates
Cats
The pooled prevalence of seropositive cats was 87.72 %
(95 % CI = 78.63, 93.28; p < 001), I2 = 0. The pooled preva-
lence of oocyst shedder cats was 17.51 % (95 % CI = 9.77,
29.36; p < 001), I2 = 19 %.
Food animals
Figure 3 shows a forest plot of the IgG logit event estimates
in food animals. The pooled estimates by potential risk
factors are presented in Table 2. The overall prevalence of
T. gondii infection was 35.5 % (95 % CI = 25.96, 46.36), and
the estimates for ruminants and non-ruminants did not
differ significantly (p > 0.05). In subgroup analyses, the
pooled seroprevalence of T. gondii in small ruminants was
34.59 % (95 % CI = 21.08, 51.12; p > 0.05), I2 = 98.9 %, with
a higher occurrence in sheep than in goats, in females than
in males, and in adults than in young animals. All single
study omitted estimates lie within the 95 % confidence
intervals of the respective overall means of each group.
Table 1 Characteristics of the eligible studies
Author Year of study Location Host Method Number Positive (%)
Zewdu et al. [27] 2010–2011 CE Goat ELISA 927 183 (19.74)
Gebremedhin et al. [28] 2010–2011 CE Sheep ELISA 1030 357 (34.66)
Teshale [29] 2005–2006 CSE Sheep, goat MDAT 641 480 (74.88)
Demissie and Tilahun [30] 2000–2001 CE Sheep, goat MDAT 468 159 (33.97)
Negash et al. [31] 1999–2000 CE Sheep, goat MDAT/ELISA 174 75 (43.10)
Gebremedhin and Gizaw [32] 2013–2014 SE Sheep, goat ELISA 184 48 (26.09)
Gebremedhin et al. [33] 2011–2012 CE Sheep, goat DAT 628 111 (17.68)
Gebremedhin et al. [34] 2012–2013 CE Camel MAT 385 187 (48.57)
Tilahun et al. [35] 2012 CE Chicken MAT 125 48 (38.40)
Gebremedhin et al. [36] 2012–2013 CE Chicken MAT 601 183 (30.45)
Gebremedhin et al. [37] 2014 CE Pig DAT 402 129 (32.09)
Dubey [38] 2011 CE Cat MAT 36 33 (91.67)
Tiao [39] 2012 CE Cat MAT 48 41 (85.42)
Negash et al. [31] 1999–2000 CE Cat Coprology 40 5 (12.5)
Dubey [38] 2011 CE Cat Coprology 36 8 (22.22)
Mellbin and Vahlquist [40] nr WCSE human SFT 267 102 (38.20)
De Roever–Bonnet [41] nr CE human SFT 99 47 (47.47)
Guebre Xabier et al. [42] 1990 CSE human ELISA 919 673 (73.23)
Eshete et al. [43] nr CE human ELISA 94 19 (20.21)
Woldemichael et al.[44] 1995–1996 CE human SFT/LAT 340 268 (78.82)
Negash et al. [45] 1999–2000 CE human MDAT 65 39 (60.00)
Yimer et al. [46] nr CE human ELISA 279 270 (96.77)
Shibre et al. [47]a 2005 CE human ELISA 90 80 (88.89)
Shimelis et al. [48] 2007 CE human ELISA 330 297 (90.00)
Tedla et al. [49]a 2009 CE human ELISA 456 434 (95.18)
Zemene et al. [50] 2011 SE human ELISA 201 163 (81.09)
Gebremedhin et al. [51] 2010–2011 CE human ELISA 425 346 (81.41)
Aleme et al. [52] 2011–2012 CE human ELISA 150 141 (94.00)
Walle et al. [53] nr NE human ELISA 204 161 (78.92)
Muluye et al. [54] 2012–2013 NE human LAT 170 130 (76.47)
Tadesse et al. [55] 2012 NE human LAT 422 171 (40.52)
Endris et al. [56] 2010–2011 NE human LAT 385 341 (88.57)
Zeweld et al. [57] 2012–2013 NE human ELISA 651 51 (7.83)
Yohannes et al. [58] 2013 SE human ELISA 170 150 (88.24)
CE, Central Ethiopia; CSE, Central and Southern Ethiopia; DAT, direct agglutination test; ELISA, enzyme linked immunosorbent assay; LA, latex agglutination test;
MAT, modified agglutination test; MDAT, modified direct agglutination test; MDAT/ELISA, modified direct agglutination test and enzyme linked immunosorbent
assay; n, sample size; NE, Northern Ethiopia; nr, not reported; SE, Southern Ethiopia; SFT, Sabin-Feldman dye test; WCSE, Western, Central and Southern Ethiopia
aData on T.gondii infection was collected before the trials
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Figure 4 shows a forest plot of the logit estimates in
humans. The pooled prevalence estimates by potential
risk factors are presented in Table 3. The overall pooled
prevalence was 74.73 % (95 % CI = 61.85, 84.36). The
pooled estimate was affected by sex, age, pregnancy,
status, cat contact/ possession and residential area but notby raw meat and raw vegetable consumption habits, and
source of water. The pooled seroprevalence in patients with
behavioral disorders (schizophrenia/bipolar disorder) was
93.88 % (95 % CI = 81.47, 98.16; p < 001), I2 = 88.2 %. All
single study omitted estimates lie within the 95 % confi-
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Fig. 2 Funnel plots of the logit IgG seroprevalence estimates (lp) in food animals (a) and humans (b)
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The moderate to high inverse variance indexes of the
study level estimates in food animals and humans re-
ported here are suggestive of potential variations that
could have been due to cat densities, environmental
and societal factors [59, 60].
The prevalence of T. gondii in cats in Ethiopia was
high. Ethiopian cats live outdoors, hunt, feed on scraps
and garbage-thus more exposed to the parasite [3]. In a
study from California, USA, the annual environmental
burden per square meter was estimated to be in the
range of 94 to 4671 oocysts, based on a low prevalence
(0.9 %) of oocysts in cat feces [61]. Therefore, if we
assume 17.51 % oocyst shedder cats in Ethiopia, and
100 million oocysts per shedder [1], the environmental
burden in urban residential areas where cats abound is
apparently high.
The overall pooled estimate in small ruminants was
considerable (34.59 %), and the odds of infection was three
times greater in adults than in young small ruminants. TheFig. 3 Forest plot of the logit IgG seroprevalence estimates (lp) in food anihigher occurrence of T.gondii infection in adults compared
to young animals is in agreement with results of studies
carried out elsewhere [62, 63]. The estimate demonstrates
the potential of T. gondii as a cause of reproductive
wastage in small ruminants, and the risk associated
with the consumption of raw products derived from
small ruminants [64, 65].
The substantially high prevalence of T. gondii infections
in humans could be due to the uncontrolled movement
of cats, the substandard living circumstances, and the
unhygienic life styles and habits that favor the transmis-
sion of the parasite from either felids or food animals.
Comparison of the present estimate with estimates for
sub-Saharan African countries (SSA) is difficult because
national survey reports or meta-analytical studies are
scarce. However, the prevalence of T. gondii infection in
Ethiopian women is apparently higher than estimates for
most developed countries (4 % in South Korea to 11 % in
USA) [60]. Therefore, assuming three million live births
each year [66], and a conservative estimate of 0.1 % birthmals
Table 2 Pooled estimates of T. gondii in food animals by potential risk factors
Risk factors p (95 % CI) Z-p Q/df Q-p I2 X2 Y-p OR (95 % CI)
All animals Overall 35.50 (25.96,46.36) 0.009 56.97 0.000 98.2
Ruminant 32.54 (22.51,44.47) 0.005 32.41 0.000 98.1 0.01 0.933 1.01 (0.87,1.16)
Non-ruminant 32.34 (28.88,35.99) 0.000 1.5 0.223 33.4
Small Ruminants Overall 34.59 (21.08, 51.12) 0.067 88.69 0.000 98.9
Sheep 33.51 (26.06, 41.90) 0.000 10.71 0.000 90.7 10.24 0.001 1.25 (1.09,1.43)
Goat 28.80 (11.17, 56.54) 0.129 100.39 0.000 99
Female 29.38 (23.06, 36.63) 0.000 9.73 0.000 89.7 23.95 0.000 1.70 (1.37,2.12)
Male 19.67 (10.80, 33.09) 0.000 11.48 0.000 91.3
Adult 34.30 (24.96, 45.07) 0.005 18.79 0.000 94.7 100.50 0.000 3.06 (2.43,3.86)
Young 14.62 (10.93, 19.26) 0.000 2.35 0.070 57.4
Midland a 53.32 (36.12, 69.76) 0.710 16.09 0.000 93.8 45.43 0.000 2.27 (1.78,2.91)
Highland 33.45. (29.78, 37.36) 0.000 0.28 0.597 0
Lowland 14.99 (8.0, 26.39) 0.000 .
I2, inverse variance index; OR, odds ratio; Q, Cochran’s X2; Y-p, probability of Yates test; Z-p, probability of Z test
aThe comparison was between midland and highland estimates
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ber of congenitally infected neonates per annum could be
about 3000.
T.gondii infection was higher in urban than in rural
inhabitants and in individuals with cats in the household
or had contact with cats. The cat population per unit area
appears to be higher in the urban than in the rural areasFig. 4 Forest plot of the logit IgG seroprevalence estimates (lp) in humansbecause of the relatively better feed resource in the former
than the latter, and as cats roam in search of food a single
cat could be a source of infection to several neighboring
urban households.
The high prevalence of T.gondii in HIV positive
individuals suggests the risk of cerebral toxoplasmosis
in patients that do not have access to HIV treatment.(lp)
Table 3 Pooled estimates of T. gondii in humans by potential risk factors
Risk factors p (95 % CI) Z-p Q/df Q-p I2 X2 Y-p OR (95 % CI)
Overall 74.73 (61.85,84.36) 0.000 70.4 0.000 98.6
Sex Male 73.54 (41.95, 91.44) 0.137 51.1 0.000 98 37.17 0.000 1.65 (1.40,1..95)
Female 62.74 (40.08,80.91) 0.269 69.4 0.000 98.6
Age Adults 69.87 (47.50,85.59) 0.080 80.2 0.000 98.8 51.06 0.000 1.95 (1.62,2.36)
Children 54.34 (24.81,81.11) 0.790 54.8 0.000 98.2
Pregnancy Pregnant 62.55 (29.88, 86.74) 0.462 56.8 0.000 98.2 152.83 0.000 3.96 (3.15,4.97)
Non-pregnant 29.59 (0.75, 95.87) 0.672 197.8 0.000 99.5
Cat Contact 85.96 (74.12, 92.90) 0.000 13.6 0.000 92.6 64.10 0.000 2.53 (2.00,3.20)
No contact 70.70 (53.74, 83.37) 0.018 27.4 0.000 96.4
Residence Urban 82.58 (73.63, 88.93) 0.000 2.7 0.000 96.3 64.04 0.000 2.06 (1.71,2.47)
Rural 69.80 (52.40, 82.91) 0.027 19.8 0.000 94.9
Meat Raw Ca 77.22 (63.85, 86.68) 0.000 18.3 0.000 94.5 0.65 0.421 1.10 (0.88,1.36)
Raw NCb 75.58 (51.22.90.11) 0.040 36.0 0.000 97.2
Vegetable Raw Ca 75.44 (53.00, 89.33) 0.028 31.8 0.000 96.9 1.45 0.229 1.19 (0.90,1.56)
Raw NCb 72.23 (35.92, 92.34) 0.222 36.6 0.000 97.3
Water Non pipe 86.65 (82.17, 90.13) 0.000 0.54 0.585 0 1.36 0.243 1.30 (0.85,2.00)
Pipe 83.45 (76.73, 88.52) 0.000 6.4 0.000 84.2
HIV Positive 81.06 (50.07, 94.81) 0.05 77.7 0.000 98.7 0.26 0.609 1.06 (0.87,1.29)
Negative 80.17 (72.47, 86.13) 0.000 6.7 0.000 85.0
I2, inverse variance index; OR, odds ratio; Q, Cochran’s X2; Y-p, probability of Yates test; Z-p probability of Z test
aConsumers
bNon-consumers
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HIV patients [69–71], and in the absence of chemo-
prophylaxis against HIV, up to 40 % of patients co-infected
with T. gondii may develop fatal Toxoplasma encephalitis
[6]. Before the start of the highly active anti-reteroviral
therapy (HAART) in Ethiopia, neural toxoplasmosis was
one of the complications [72] with mortality in more than
a third of the patients [72, 73], and after the initiation of
HAART, immune reconstitution inflammatory syndrome
(IRIS) was one of the sequels of toxoplasmosis [74–76].
To date, there have been only two studies that reported
the prevalence of T.gondii in patients with schizophrenia/
bipolar disorders and the study level estimates were
greater than 88 % [47, 49]. Meta-analytical studies
have also shown higher odds of schizophrenia (OR = 2.73)
[77, 78], and epilepsy (OR = 4.8) [13] in T.gondii sero-
positive than in seronegative individuals, and positive
associations of T.gondii seroprevalence with traffic acci-
dents [79–81], and suicide attempts and success [82] have
been recorded elsewhere.
Implications and limitations
This study demonstrates the importance of toxoplasmosis
in small ruminant production and its public health impact.
The control of the disease in a country where most cats
are stray, and the food animal management system ismainly of an extensive type is difficult. Therefore, public
education as regards the value of cooked meat and washed
vegetables, and hygienic practice could reduce the
transmission of the parasite and the consequences of
infection in humans. Secondly, although a large scale
neonatal screening program and treatment of infected
neonates at a national level is not an economically viable
strategy against congenital infections, initiation of such a
program at least in urban areas where there are individuals
who afford the medical costs could somehow reduce the
impacts of the disease to a limited extent.
As the numbers of eligible studies in each stratum
were small and all regions of the country have not been
covered in the studies, the estimates and the predictive
values of the risk factors may vary depending on factors
that may involve animal, environmental and societal
variables. However, the pooled estimates highlight the
overall magnitude of Toxoplasma infections in animals
and humans in Ethiopia; the heterogeneity statistics show
the variability of the study level estimates and potential
areas of research, and the crude odds ratios depict the
relative importance of the risk factors.
Conclusions
Toxoplasmosis is highly prevalent in Ethiopia, and could
be a cause of considerable reproductive wastage in small
Gebremedhin and Tadesse Parasites & Vectors  (2015) 8:291 Page 8 of 9ruminants and multiple diseases in humans. Educational
programs, and serological screening and treatment of
neonates when possible could help to reduce the national
impacts of the disease. Further studies are needed to
describe the epidemiology of the disease at a national
level in Ethiopia.
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